193 related articles for article (PubMed ID: 15892954)
1. Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture.
Aus dem Siepen M; Lohmann V; Wiese M; Ross S; Roggendorf M; Viazov S
Virology; 2005 Jun; 336(2):131-6. PubMed ID: 15892954
[TBL] [Abstract][Full Text] [Related]
2. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
Pawlotsky JM; Germanidis G; Neumann AU; Pellerin M; Frainais PO; Dhumeaux D
J Virol; 1998 Apr; 72(4):2795-805. PubMed ID: 9525599
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
5. Effect of alpha interferon on the hepatitis C virus replicon.
Guo JT; Bichko VV; Seeger C
J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
[TBL] [Abstract][Full Text] [Related]
6. Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness.
Schiappa DA; Mittal C; Brown JA; Mika BP
J Infect Dis; 2002 Apr; 185(7):868-77. PubMed ID: 11920310
[TBL] [Abstract][Full Text] [Related]
7. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
Gale MJ; Korth MJ; Tang NM; Tan SL; Hopkins DA; Dever TE; Polyak SJ; Gretch DR; Katze MG
Virology; 1997 Apr; 230(2):217-27. PubMed ID: 9143277
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
9. Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.
Lin HM; Wang JC; Hu HS; Wu PS; Wang WH; Wu SY; Yang CC; Yeh TK; Hsu TA; Jiaang WT; Chao YS; Chern JH; Yueh A
Antimicrob Agents Chemother; 2013 Feb; 57(2):723-33. PubMed ID: 23165461
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052.
Wang C; Huang H; Valera L; Sun JH; O'Boyle DR; Nower PT; Jia L; Qiu D; Huang X; Altaf A; Gao M; Fridell RA
Antimicrob Agents Chemother; 2012 Mar; 56(3):1350-8. PubMed ID: 22214777
[TBL] [Abstract][Full Text] [Related]
11. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
12. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
13. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
Tsai YH; Kuang WF; Lu TY; Kao JH; Lai MY; Liu CJ; Chen PJ; Hwang LH
J Hepatol; 2008 Dec; 49(6):899-907. PubMed ID: 18842320
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of the 5'UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients.
Bolcic F; Laufer N; Torres C; Cassino L; Reynoso R; Quarleri J
Antiviral Res; 2012 Aug; 95(2):72-81. PubMed ID: 22683884
[TBL] [Abstract][Full Text] [Related]
15. [Construction and sequence analysis of recombinant HCV-1b replicon by replacing NS5A region].
Li J; Zhou B; Zhou Y; Zeng Y; Li W; Wang J; Zhang J; Zhang H; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):46-9. PubMed ID: 22366003
[TBL] [Abstract][Full Text] [Related]
16. Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.
Sede M; Laufer N; Ojeda D; Gun A; Cahn P; Quarleri J
Arch Virol; 2013 Sep; 158(9):1907-15. PubMed ID: 23553458
[TBL] [Abstract][Full Text] [Related]
17. The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.
He Y; Yan W; Coito C; Li Y; Gale M; Katze MG
J Gen Virol; 2003 Mar; 84(Pt 3):535-543. PubMed ID: 12604803
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain.
Lanford RE; Guerra B; Lee H
Virology; 2006 Nov; 355(2):192-202. PubMed ID: 16919701
[TBL] [Abstract][Full Text] [Related]
19. The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.
Goyal A; Hofmann WP; Hermann E; Traver S; Hissar SS; Arora N; Blum HE; Zeuzem S; Sarrazin C; Sarin SK
Med Microbiol Immunol; 2007 Mar; 196(1):11-21. PubMed ID: 16955308
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
